DIA Biosimilars 2013

Phlexglobal

Phlexglobal refocuses company as ‘The TMF Experts’

Wednesday, June 20, 2012 12:37 PM

Following 12 months of significant international expansion, Phlexglobal, the creaetor of the first commercial electronic Trial Master File (eTMF) solution, PhlexEview, has announced its new corporate repositioning as ‘The TMF Experts,’ with a brand new image and website.

More... »

Cenduit: Now with Patient Reminders

Phlexglobal recruits research nurses for trials

Tuesday, March 22, 2011 11:52 AM

U.K.-based CRO Phlexglobal has expanded its resourcing capabilities by launching a Research Nurse Bank to supply skilled nursing staff on a temporary basis to both commercial and National Health Service clients, according to PharmaTimes.

More... »

CRF Health – eCOA Forum

Phlexglobal Expands into the U.S.

Friday, June 18, 2010 09:16 AM

Phlexglobal, a U.K.-based CRO that specializes in software and services that help drug sponsors manage clinical trial documents, has opened an office in Carlsbad, Calif., as the company looks to expand its business operations into the United States.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs